Scientific Library
Luciferase promoter reporter clones
Cell-based assays, screening for pathway activation or inhibition are classically done with promoter reporter clones expressing Firefly luciferase. Brighter, more stable, more sensitive, more convenient
shRNA set with improved performances
Optimal knock-down can be done by a shRNA sequence that depends on the gene expression level and the cell type. Usually, 4 shRNA should be tested to find the one inducing a minimum of 70% increase of the
ORF expressing Lentiviral system
ORF expression in Mammalian cells is very useful for many applications: protein production with HEK293, over-expression of tagged protein for immuno-tracking or immuno-precipitation, development of a cell
Gene knock-out in hard-to-transfect cells
Gene knock-out, which is gene editing leading to loss of function, just requires delivering into cells the 2 CRISPR system actors: the CAS9 endonuclease and the specific guide RNA to target the gene of
New - you know CRISPR, now it's Prime Editing
This month, a new leap forward in gene editing has been published in Nature under the title 'Search-and-replace genome editing without double-strand breaks or donor DNA'. DOI: 10.1038/s41586-019-1711-4.
How to make efficient Lipid Nanoparticles for RNA delivery
How to make efficient Lipid Nanoparticles for RNA delivery
Even if RNA-based therapeutics have been under development for over 30 years, it was the COVID-19 pandemic that brought them into the limelight,
What is the future of mRNA based therapeutics, and their main challenges?
mRNA is a ribonucleic acid used by cells as an intermediate carrier of the genetic information contained in the DNA to synthesize proteins, and corresponds to the copy of one of the two strands of DNA.
Elevate Your Proteomic Research with Tebubio’s Biomarker & Biostatistics Expertise
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory Platform, led by a team of expert scientists and biostatisticians, can help you overcome challenges
Biological samples solutions: the chalenges of in vitro models
Access this on-demand webinar to discover how Tebubio leverages its expertise to help you source high-quality human biological samples, enabling you to develop the in-vitro model best suited to your research
Accelerate your mRNA-based proof-of-concepts studies with Tebubio
Watch this on-demand webinar to learn how Tebubio's Contract Research Service laboratory and experts can help you overcome the key challenges in developing innovative mRNA-based therapies.
How to Identify Efficient LNP Formulations for Your Model? Insights from Tebubio's Delivery Platform
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory can help you screen the most effective LNP formulations for optimal RNA delivery into your cell
Development and Imaging Validation of Fluorescent Lipid Nanoparticles for RNA Delivery Applicable to Personalized In Vitro Oncology Models
Discover how Tebubio's innovative LNP platform enables real-time tracking of RNA delivery in oncology models. Explore our latest findings and applications for personalized medicine.